News About: Pharm. Affairs


Obesity therapy Saxenda lands in 10 general hospitals including Seoul National University Hospital

Novo Nordisk Korea(CEO Rana Azfar Zafar) announced on the 21st that ‘Saxenda® (generic name: liraglutide 3.0mg),’ the world’s first and only GLP-1(Glucagon-Like Peptide 1) analogue for the treatment of obesity, will b...

High chance for Emergency Household Medicine List meeting to be held this June

There is a high chance for the 6th Deliberative Committee for Adjustment of the Emergency Household Medicine List meeting, which has been postponed for about a half year, to be held next month. Based on a survey resu...

Korean pharmas being active with developing incrementally new drugs while keeping off from new drugs

While slowing down with getting approval for new drugs, Korean pharmaceutical companies are being active in developing incrementally modified drugs in combination with other substances. According to the Ministry of F...

7 Seoul districts including Kwanak and Seocho had a decrease in the number of pharmacies

It was reported that 176 pharmacies were shut down and 200 were newly opened in Seoul on the 1st quarter. In addition to this, 7 districts(Gu) including Gwanak-gu and Seocho-gu had less pharmacies. According to the ...

‘Diabetes + hyperlipidemia’ combination therapy market fueled with 3 new products

The market of diabetes and hyperlipidemia has been fueled. On the 10th, the Ministry of Food and Drug Safety(MFDS) approved CJ HealthCare’s Atomet SR Tab 10/500mg, 10/750mg, 20/500mg and 20/750mg, Daewoong Pharmaceut...

CCEJ, “Pharmaceutical association must throw away egoism and be more active in expanding emergency household medicines”

The Citizens’ Coalition for Economic Justice(CCEJ) announced a stance to enlarge the number of medicinal drugs selling at convenient stores to raise drug accessibility. On the 11th, the CCEJ made a criticism about th...

248 new drugs have been approved in Korea since 2010

There have been 248 new drugs approved in Korea since 2010. In the total new drugs approved, anticancer drugs accounted the most with 50 products, and it was followed by antidiabetics. According to the new drug list ...

Pharmas active in developing antihypertensive combination drugs

Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension. Moreover, antihypertensives are reportedly moving towards a trend with...

Increase in OTC drug approval

The number of OTC drug approvals has increased since this year. The percentage of approvals for OTC drugs is reaching 27% by this April. According to the Ministry of Food and Drug Safety(MFDS) Online Library, there w...

Will Cyramza with health insurance benefits broaden options for stomach cancer patients?

Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients? Lilly Korea, on th...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.